🇺🇸 FDA
Pipeline program

AMBROXOL , Microcrystalline cellulose

NL77347.042.22

Phase 2 small_molecule active

Quick answer

AMBROXOL , Microcrystalline cellulose for Parkinson's disease is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Parkinson's disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials